GoodRx Holdings (GDRX) Total Current Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Total Current Liabilities across 8 years of filings, most recently posting $859.2 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $859.2 million, up 731.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $859.2 million (up 731.08% YoY), and the FY2025 annual result was $246.0 million, up 98.54% from the prior year.
• Total Current Liabilities came in at $859.2 million for Q1 2026 at GoodRx Holdings, up from $246.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $859.2 million in Q1 2026 to a low of $59.4 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $114.4 million (2024), against an average of $157.1 million.
• Across the five-year window, Total Current Liabilities retreated 11.28% in 2025 and soared 731.08% in 2026, its largest moves.
• GoodRx Holdings' Total Current Liabilities stood at $76.3 million in 2022, then jumped by 60.59% to $122.6 million in 2023, then grew by 1.1% to $123.9 million in 2024, then soared by 98.54% to $246.0 million in 2025, then soared by 249.26% to $859.2 million in 2026.
• The last three Total Current Liabilities figures came in at $859.2 million (Q1 2026), $246.0 million (Q4 2025), and $181.9 million (Q3 2025), per Business Quant data.